This study follows 94 people who received the FDA-approved H3 total ankle replacement for arthritis. Researchers will track serious device-related problems and how well the ankle works over 2 to 5 years. The goal is to confirm the device's safety and effectiveness in real-world u…
Phase: NA • Sponsor: DT MedTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC